Opportunity Information: Apply for PAR 13 366
Apply for PAR 13 366
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Mar 4, 2015 and posted on Sep 27, 2013.
- Applicants must submit their applications by Mar 2, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: City or township governments Public housing authorities/Indian housing authorities Small businesses Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply.Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18) funding opportunity (PAR-13-366) is a National Institutes of Health (NIH) grant program designed to support real-world, practice-based research that can strengthen how diabetes is prevented and treated in everyday healthcare environments. Rather than focusing on tightly controlled laboratory-style studies, this announcement emphasizes pragmatic research: studies that are embedded in routine clinical care and are intended to produce results that are immediately useful to healthcare systems, clinicians, and decision-makers. The central aim is to test practical, feasible, and potentially sustainable approaches that improve both the processes of care (how care is delivered) and patient health outcomes for people who have diabetes or who are at risk of developing it. A key expectation is that findings will be relevant to representative healthcare settings and could help shape routine clinical practice as well as inform policy.
This opportunity uses the NIH R18 mechanism, which is geared toward research demonstration and dissemination projects. In plain terms, NIH is looking for projects that do more than prove a concept; they should show how an intervention or care strategy performs when implemented under normal conditions in clinics, health systems, or other established healthcare delivery settings. The work supported under this FOA should be grounded in the realities of clinical workflows, staffing, patient populations, and operational constraints, with an eye toward strategies that can be maintained after the grant ends. The emphasis on dissemination also signals interest in lessons that can be shared and adopted more broadly, not just within a single site.
The program sits within a health-focused activity area and is tied to CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), aligning it with NIH efforts to improve outcomes related to diabetes and its complications. The award ceiling listed is $500,000, and the opportunity does not require cost sharing or matching, meaning applicants are not obligated to contribute non-federal funds as a condition of receiving the award.
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township, and special district governments; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; public and private institutions of higher education; independent school districts; nonprofit organizations both with and without 501(c)(3) status; and for-profit organizations, including small businesses. The eligibility language also explicitly includes a range of mission-serving and community-rooted institutions and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, the FOA makes clear that non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed under NIH policy as referenced in the announcement.
Key timeline fields in the source data indicate the FOA was originally posted on September 27, 2013, with an original closing date of November 1, 2016. The record also shows later administrative dates (creation date March 4, 2015; a current closing date listed as March 2, 2015; and an archive date of April 2, 2015), which suggests the particular listing captured here reflects a specific snapshot in time and may have been archived after that period. Anyone seeking to apply would typically need to confirm the current status of the announcement and due dates via the official NIH funding page linked in the record.
For applicants looking for full details, the official announcement is available through the NIH grants website at http://grants.nih.gov/grants/guide/pa-files/PAR-13-366.html. If there are technical issues accessing the announcement or linking to it, the provided contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
1) What is the Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18) opportunity?
It is a National Institutes of Health (NIH) funding opportunity (PAR-13-366) that supports real-world, practice-based research aimed at improving diabetes prevention and diabetes care in routine healthcare settings.
2) What does "pragmatic research" mean in this program?
In this announcement, pragmatic research refers to studies embedded in everyday clinical care rather than tightly controlled, laboratory-style studies. The goal is to generate findings that are immediately useful to healthcare systems, clinicians, and decision-makers.
3) What is the central aim of this funding opportunity?
The central aim is to test practical, feasible, and potentially sustainable approaches that improve (1) processes of care (how care is delivered) and (2) patient health outcomes for people who have diabetes or who are at risk of developing diabetes.
4) What kinds of outcomes is NIH expecting projects to improve?
Projects are expected to target improvements in care delivery processes and patient health outcomes related to diabetes prevention and care, with results that can inform routine clinical practice and potentially policy.
5) What does the R18 mechanism support?
The opportunity uses the NIH R18 mechanism, which is geared toward research demonstration and dissemination projects. In practical terms, it supports projects that show how interventions or care strategies perform under normal conditions in real healthcare delivery settings.
6) How is this different from a traditional controlled clinical study?
Rather than emphasizing highly controlled conditions, this program emphasizes interventions implemented within routine workflows and real operational constraints, aiming for findings that are broadly relevant to representative healthcare settings.
7) What types of settings are these projects expected to take place in?
The announcement emphasizes established healthcare delivery settings such as clinics, health systems, or other routine care environments where interventions can be embedded into everyday practice.
8) Does NIH expect projects to be sustainable after the grant ends?
Yes. A stated emphasis is on approaches that fit real-world workflows, staffing, patient populations, and operational constraints, with an eye toward strategies that can be maintained after the grant period.
9) Is dissemination part of the expectation for funded projects?
Yes. Because the R18 mechanism is aligned with demonstration and dissemination, the announcement signals interest in lessons that can be shared and adopted more broadly, beyond a single site.
10) What is the CFDA number associated with this program?
The program is tied to CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
11) What is the maximum award amount listed for this opportunity?
The award ceiling listed in the provided information is $500,000.
12) Is cost sharing or matching required?
No. The opportunity states that cost sharing or matching is not required, meaning applicants are not obligated to contribute non-federal funds as a condition of receiving the award.
13) Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governmental entities. Examples listed include state, county, city or township, and special district governments; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; public and private institutions of higher education; independent school districts; nonprofit organizations (with or without 501(c)(3) status); and for-profit organizations, including small businesses.
14) Are community-rooted or mission-serving institutions specifically included?
Yes. The eligibility language explicitly includes institutions and organizations such as HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, faith-based organizations, community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
15) Are non-U.S. entities eligible to apply?
No. The announcement states that non-U.S. entities are not eligible to apply.
16) Are non-U.S. components of U.S. organizations eligible?
No. The provided information states that non-U.S. components of U.S. organizations are not eligible.
17) Are foreign components allowed under this opportunity?
No. The information provided indicates that foreign components are not allowed under NIH policy as referenced in the announcement.
18) When was this funding opportunity posted, and what are the due dates shown?
The record indicates the FOA was originally posted on September 27, 2013, with an original closing date of November 1, 2016. The same record also shows later administrative dates (creation date March 4, 2015; a current closing date listed as March 2, 2015; and an archive date of April 2, 2015), suggesting the listing may represent a snapshot in time and may have been archived.
19) How should applicants confirm whether the opportunity is currently open?
Anyone seeking to apply should confirm the current status and due dates using the official NIH funding announcement page referenced in the record.
20) Where can applicants find the official announcement text?
The official announcement is available on the NIH grants website at: http://grants.nih.gov/grants/guide/pa-files/PAR-13-366.html
21) Who should be contacted for technical issues accessing the announcement or link?
For technical issues accessing the announcement or linking to it, the provided contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
22) What is NIH ultimately trying to achieve through this program?
NIH is aiming to support research that strengthens how diabetes is prevented and treated in everyday healthcare environments, producing results that can be applied in routine practice and that may inform broader decision-making and policy.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34)
Previous opportunity: Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 366
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 366) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34) Apply for PAR 13 367 Funding Number: PAR 13 367 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological Diseases (U01) Apply for RFA DK 13 026 Funding Number: RFA DK 13 026 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Biomarkers for Diabetes Complications Non Invasive Measures in the Eye (DP3) Apply for RFA DK 13 027 Funding Number: RFA DK 13 027 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Limited Competition for the Data Coordinating Center for Type I Diabetes TrialNet (UC4) Apply for RFA DK 13 508 Funding Number: RFA DK 13 508 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| George M. OBrien Urology Cooperative Research Centers Program (U54) Apply for RFA DK 13 020 Funding Number: RFA DK 13 020 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Seeding Collaborations for Translational Research to Discover and Develop New Therapies for Diseases and Conditions within NIDDKs Mission (Revisions) (R01) Apply for PAR 14 006 Funding Number: PAR 14 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $75,000 |
| Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas (SBIR) (R43/R44) Apply for RFA DK 13 028 Funding Number: RFA DK 13 028 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to NIDDK (STTR (R41/R42)) Apply for PA 14 054 Funding Number: PA 14 054 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (SBIR (R43/R44)) Apply for PA 14 055 Funding Number: PA 14 055 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Small Business Technology Transfer Research (STTR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) STTR (R41/R42) Apply for PA 14 059 Funding Number: PA 14 059 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Small Business Innovation Research (SBIR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) (SBIR (R43/R44)) Apply for PA 14 058 Funding Number: PA 14 058 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Research Using Subjects From Selected Type I Diabetes Clinical Studies (Living Biobank) (DP3) Apply for PAR 14 064 Funding Number: PAR 14 064 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3) Apply for PAR 14 065 Funding Number: PAR 14 065 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Cystic Fibrosis Research and Translation Core Center (P30) Apply for RFA DK 13 007 Funding Number: RFA DK 13 007 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Systems for Health Apply for RFA 641 14 00002 Funding Number: RFA 641 14 00002 Agency: Ghana USAID Accra Category: Food and Nutrition Health Funding Amount: $68,000,000 |
| Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01) Apply for RFA DK 14 501 Funding Number: RFA DK 14 501 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $400,000 |
| Limited Competition Continuation of the Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01) Apply for RFA DK 14 502 Funding Number: RFA DK 14 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $10,000,000 |
| Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01) Apply for RFA DK 14 003 Funding Number: RFA DK 14 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $300,000 |
| Limited Competition for the Data Coordinating Center of Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01) Apply for RFA DK 14 503 Funding Number: RFA DK 14 503 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $2,500,000 |
| Reagents for Glucagon and Incretin Research (R41/R42) Apply for PA 14 204 Funding Number: PA 14 204 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 366", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.